United States

United States

2023, The Life Sciences Law Review, Edition 11

The United States accounts for about 45 per cent of the global pharmaceutical market and is the largest single investor in research and development of new products. The National Institutes of Health, the primary federal agency that funds biomedical research, has a proposed budget of more than US$62 billion for FY2023 and manufacturers based in the United States spend substantially more than that each year on research and development.